menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

A Deeper Understanding of Maternal Alloimmunization and Hemolytic Disease of the Fetus/Newborn

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

While HDFN is considered a rare disease, the outcomes can be devastating, making it essential to identify and manage those who may be at risk.

  • Sponsored by

  • Overview

    Hemolytic disease of the fetus/newborn (HDFN) may be rare, but it is important to recognize and diagnose the disease and ensure appropriate patient management since the consequences in cases that go undiagnosed or are poorly managed can be devastating. To help us gain a better understanding of maternal alloimmunization and the risk for HDFN in pregnancy, Dr. Charles Turck speaks with Dr. Kenneth Moise, Director of the Comprehensive Fetal Care Center in Texas. 

    © Janssen Pharmaceuticals, Inc. 2022 12/21 cp-272563v1

Schedule22 May 2022
Webpack App